Hepalatide (L47)

Hepalatide · Shanghai HEP Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hepalatide (L47), covering 2017-01-23 to 2017-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers [Phase 1]